Standout Papers

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advance... 2016 2026 2019 2022 661
  1. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors (2016)
    Muhammad S. Beg, Andrew Brenner et al. Investigational New Drugs

Immediate Impact

2 by Nobel laureates 14 from Science/Nature 61 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Polymeric Nanoparticles for Drug Delivery
2024 Standout
1 intermediate paper

Works of Jasgit C. Sachdev being referenced

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
2018
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
2016

Author Peers

Author Last Decade Papers Cites
Jasgit C. Sachdev 1540 1700 539 917 124 3.3k
Minoru Kitago 1799 1045 693 1009 189 3.7k
Rodney B. Luwor 1433 1995 420 844 91 3.6k
Giulio Francia 1471 1503 532 840 66 3.1k
Galen Hostetter 1628 2471 491 993 89 4.4k
Antonio Daga 1317 2233 351 774 95 4.1k
Brett L. Carlson 1242 1870 550 708 67 3.5k
Dominic Fan 1953 2001 854 754 72 4.1k
Zahra Madjd 1611 1818 464 906 170 3.8k
Ranjit S. Bindra 1304 2541 624 1329 120 4.0k
Carlotta A. Glackin 1863 3049 427 1069 78 5.2k

All Works

Loading papers...

Rankless by CCL
2026